Items where authors include "Rantala, J.K."

Article

Rahman, M.M. orcid.org/0000-0002-2996-8109, Wells, G., Rantala, J.K. et al. (3 more authors) (2024) In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges. Expert Review of Clinical Immunology, 20 (8). pp. 821-838. ISSN 1744-666X

Nykänen, N., Mäkelä, R., Arjonen, A. et al. (8 more authors) (2021) Ex vivo drug screening informed targeted therapy for metastatic parotid squamous cell carcinoma. Frontiers in Oncology, 11. 735820.

Mäkelä, R., Arjonen, A., Suryo Rahmanto, A. et al. (7 more authors) (2020) Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma. Neoplasia, 22 (9). pp. 390-398. ISSN 1476-5586

Brunner, A., Suryo Rahmanto, A., Johansson, H. et al. (10 more authors) (2020) PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer. eLife, 9. e57894.

Arjonen, A., Mäkelä, R., Härmä, V. et al. (4 more authors) (2020) Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma. Lung Cancer, 145. pp. 27-32. ISSN 0169-5002

Mäkelä, R., Arjonen, A., Härmä, V. et al. (7 more authors) (2020) Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma. BMC Cancer, 20 (1). 590. ISSN 1471-2407

Rantala, J.K. orcid.org/0000-0002-4999-5585, Makela, R., Aaltola, A.-R. et al. (5 more authors) (2011) A cell spot microarray method for production of high density siRNA transfection microarrays. BMC Genomics, 12. 162. ISSN 1471-2164